Alberto Santagostino
Alberto Santagostino publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments and Myeloproliferative Neoplasms: Diagnosis and Treatment.
- World rank
- #2,056,287 of 7,710,434 ranked researchers
- Rank in France
- #89,377 of 324,115
- Works
- 46
- Citations
- 961
- Citations per work
- 20.9
What does Alberto Santagostino research?
Alberto Santagostino's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2963.6%
- Medicine2963.6%
- Everything else1225.4%
- Life Sciences511.0%
- 1Hematology30% of their works
- 2Genetics16% of their works
- 3Molecular Biology11% of their works
- 4Oncology10% of their works
- 5Pulmonary and Respiratory Medicine4% of their works
- 6Cardiology and Cardiovascular Medicine4% of their works
Research topics
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Cancer Treatment and Pharmacology
Which keywords describe Alberto Santagostino's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Diagnosis Criteria, International Myeloma Working Group, JAK2 Mutation, Myelofibrosis and BCR-ABL.
- PROTACs
- HDAC Inhibitors
- BET Bromodomains
- Chronic Lymphocytic Leukemia
- BCR-ABL
- JAK2 Mutation
- Diagnosis Criteria
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- International Myeloma Working Group
- Myelofibrosis
- Imatinib
- Genomic Aberrations
- Chemotherapy-Induced Peripheral Neuropathy
- Histone Deacetylases
- Taxanes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Prognostic Factors212 topics
- AML141 topic
- Acute Myeloid Leukemia141 topic
- Diagnosis Criteria131 topic
- International Myeloma Working Group131 topic
- JAK2 Mutation91 topic
- Myelofibrosis91 topic
- BCR-ABL81 topic
- Imatinib81 topic
- Chronic Lymphocytic Leukemia71 topic
- Genomic Aberrations71 topic
- BET Bromodomains41 topic
- Chemotherapy-Induced Peripheral Neuropathy41 topic
- HDAC Inhibitors41 topic
- Histone Deacetylases41 topic
- PROTACs41 topic
- Taxanes41 topic
Where does Alberto Santagostino work?
Alberto Santagostino's main affiliation in the publication record is Centre Hospitalier de Troyes, France.
How many publications and citations does Alberto Santagostino have?
OpenAlex counts 46 works and 961 citations for Alberto Santagostino, an h-index of 13, ranking #2,056,287 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Alberto Santagostino. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.